MB-triple V protocol

chemotherapy protocol consisting of mitoxantrone, behenoyl-arabinoside, etoposide, vincrstine & vindesine; used in treatment of acute leukemia

Networked: 0 relevant articles (0 outcomes, 0 trials/studies)

Therapy Context: Research Results

Therapeutics: 1158551
- Drug Therapy: 293145
  - Combination Drug Therapy: 12066
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - MB-triple V protocol
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - MB-triple V protocol
- Clinical Protocols
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - MB-triple V protocol
Heterocyclic Compounds: 198
Nucleic Acids, Nucleotides, and Nucleosides: 1
- Nucleosides: 6847
  - Pyrimidine Nucleosides: 50
    - Cytidine: 535
      - Cytarabine: 6662
        MB-triple V protocol
  - Arabinonucleosides: 1
    - Cytarabine: 6662
      - MB-triple V protocol
Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Polycyclic Aromatic Hydrocarbons: 2020
        Naphthalenes: 18
        Tetrahydronaphthalenes: 1
        Podophyllotoxin: 562
        Etoposide: 10706
        MB-triple V protocol
        Anthracenes: 12
        Anthrones: 12
        Anthraquinones: 788
        Mitoxantrone: 2907
        MB-triple V protocol
- Quinones: 434
  - Anthraquinones: 788
    - Mitoxantrone: 2907
      - MB-triple V protocol
Polycyclic Compounds: 6
- Polycyclic Aromatic Hydrocarbons: 2020
  - Naphthalenes: 18
    - Tetrahydronaphthalenes: 1
      - Podophyllotoxin: 562
        Etoposide: 10706
        MB-triple V protocol
  - Anthracenes: 12
    - Anthrones: 12
      - Anthraquinones: 788
        Mitoxantrone: 2907
        MB-triple V protocol
Carbohydrates: 22023
- Glycosides: 2119
  - Glucosides: 639
    - Etoposide: 10706
      - MB-triple V protocol